NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

For more than 200 years, ever since a British apothecary named James Parkinson in 1817 published “An Essay on the Shaking Palsy,” scientists have searched for the reasons why some people develop ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

Explore off times in advanced Parkinson's disease, understand symptoms, communicate with your doctor, and consider treatment strategies and lifestyle adjustments.

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...

A personal play about living with Parkinson’s disease that proved a big hit in Orlando last year will return this weekend for ...

Researchers at McGill University have uncovered a surprising twist in how dopamine affects movement, overturning a ...

A new study from UCLA Health has found that long-term residential exposure to the pesticide chlorpyrifos is associated with ...